These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24374906)

  • 21. Effects of carbamazepine on serum antidepressant concentrations in psychiatric patients.
    Leinonen E; Lillsunde P; Laukkanen V; Ylitalo P
    J Clin Psychopharmacol; 1991 Oct; 11(5):313-8. PubMed ID: 1765574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and ethanol.
    Troy SM; Turner MB; Unruh M; Parker VD; Chiang ST
    J Clin Pharmacol; 1997 Nov; 37(11):1073-81. PubMed ID: 9506002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular safety in depressed patients: focus on venlafaxine.
    Feighner JP
    J Clin Psychiatry; 1995 Dec; 56(12):574-9. PubMed ID: 8530334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials.
    Bakish D
    Postgrad Med; 1999 Nov; 106(6 Suppl):24-30. PubMed ID: 19667501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium.
    Troy SM; Parker VD; Hicks DR; Boudino FD; Chiang ST
    J Clin Pharmacol; 1996 Feb; 36(2):175-81. PubMed ID: 8852394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy.
    ter Horst PG; Larmené-Beld KH; Bosman J; van der Veen EL; Wieringa A; Smit JP
    J Clin Pharm Ther; 2014 Oct; 39(5):541-4. PubMed ID: 24989434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.
    Uhr M; Grauer MT; Holsboer F
    Biol Psychiatry; 2003 Oct; 54(8):840-6. PubMed ID: 14550684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states.
    Homero de Souza Filho J; Bonifácio FN; Bedor DC; Ramos VL; de Sousa CE; Sardón LL; Gonçalves TM; Moreira RC; Leal LB; de Santana DP
    Clin Ther; 2010 Nov; 32(12):2088-96. PubMed ID: 21118744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
    Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
    Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nefazodone and venlafaxine: two new agents for the treatment of depression.
    Goldberg RJ
    J Fam Pract; 1995 Dec; 41(6):591-4. PubMed ID: 7500069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
    Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
    Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity.
    Sauer H; Huppertz-Helmhold S; Dierkes W
    Pharmacopsychiatry; 2003 Sep; 36(5):169-75. PubMed ID: 14571350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of cimetidine on the disposition kinetics of the antidepressant venlafaxine.
    Troy SM; Rudolph R; Mayersohn M; Chiang ST
    J Clin Pharmacol; 1998 May; 38(5):467-74. PubMed ID: 9602962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin syndrome induced by administration of venlafaxine and phenelzine.
    Heisler MA; Guidry JR; Arnecke B
    Ann Pharmacother; 1996 Jan; 30(1):84. PubMed ID: 8773172
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
    Mazeh D; Shahal B; Aviv A; Zemishlani H; Barak Y
    Int Clin Psychopharmacol; 2007 Nov; 22(6):371-5. PubMed ID: 17917556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.